Seth Berkley: The troubling reason why vaccines are made too late ... if they're made at all
Seth Berkeley: Problematični razlog zbog kojeg cjepiva proizvodimo prekasno...ako uopće proizvodimo
Epidemiologist Seth Berkley is leading the charge to make sure vaccines are available to everyone, including those living in the developing world. Full bio
Double-click the English transcript below to play the video.
glavoboljom, bolovima u mišićima,
nose and gums.
nosa i desni.
from low blood pressure.
zbog niskog krvnog tlaka.
a mosquito-born disease
bolesti koju uzrokuju komarci
an effective therapy or a vaccine,
učinkovita terapija ili cjepivo
the number of people
that we've known about it.
koliko znamo za nju.
in the news recently,
vijestima u posljednje vrijeme,
all of the headlines and the fear.
deeply rooted about it,
and fascinates us
of a horrible death is high.
rizik užasne smrti je visok.
effective therapy or vaccine available.
učinkovitu terapiju ili dostupno cjepivo.
as many people as other diseases.
poput drugih bolesti.
than viruses such as flu or measles.
virusa, kao na primjer gripe ili ospica.
that it kills us and we can't treat it.
ubija i da ju ne možemo izliječiti.
that comes with Ebola.
koja dolazi s ebolom.
that seems to defy modern medical science.
da prkosi današnjoj modernoj medicini.
vaccine candidates available now
cjepiva koja su dostupna
are just going into clinical trials now?
prolaze klinička testiranja?
problem we have
for infectious diseases.
skupina za te bolesti
to pay for vaccines.
u mogućnosti platiti cjepiva.
of market incentives
who are at risk in wealthy countries.
oboljenje nije u bogatim zemljama.
no market at all,
ne postoji nikakvo tržište,
in late-stage clinical trials now,
cjepiva u stadiju kliničkih istraživanja
of a somewhat misguided fear.
and the anthrax attacks,
people perceived Ebola
počeli doživljavati ebolu
wasn't fully developed at this point?
još nije potpuno razvijeno?
it was really difficult --
što je stvarno teško --
to weaponize the virus,
naoružati virus,
of the financial risk in developing it.
rizika razvijanja tog cjepiva.
the pathogen poses to people,
patogen predstavlja za ljude,
to develop these vaccines.
riziku razvoja cjepiva.
is expensive and complicated.
of millions of dollars
and turn it into a viable vaccine.
pretvori u učinkovito cjepivo.
to remove some of these barriers.
ukloniti neke od prepreka.
when there's a complete market failure.
potpuni neuspjeh tržišta.
or some type of subsidy.
vrstu novčane subvencije.
at being able to figure out
that most threaten us.
we then create the ability
stvaramo mogućnost
epidemiological and laboratory networks
i laboratorijske veze
and categorizing these pathogens.
i kategorizirati te patogene.
and genetic diversity,
i genetske raznolikosti,
to help us understand
za razumijevanje
immunologically,
with a complete market failure,
suočiti s potpunim neuspjehom tržišta,
we view and prevent infectious diseases.
na zarazne bolesti i njihovu prevenciju.
until we see evidence
before we consider it as one.
prije no što ju smatramo prijetnjom.
of an infectious disease,
transported to wealthy countries,
prijenosa u bogate zemlje,
of dedicated vaccine companies,
za razvoj cjepiva
in the Ebola countries --
učinkovitosti u zemljama pogođenim ebolom
that are following behind.
permanently patrolling the oceans
u stalnoj ophodnji oceana
that almost certainly will never happen.
sigurno nikada neće obistiniti.
and evolutionarily certain
bliskog i evolucijski sigurnog
it's not a question of "if," but "when."
pitanje "ako", nego pitanje "kada".
epidemics like Ebola,
epidemije kao što je ebola,
of investing in vaccine development
as the ultimate deterrent --
kao na posljednju opomenu --
pobrinuti da bude dostupno,
praying we never have to use it.
to nikada nećemo morati iskoristiti.
ABOUT THE SPEAKER
Seth Berkley - Vaccine visionaryEpidemiologist Seth Berkley is leading the charge to make sure vaccines are available to everyone, including those living in the developing world.
Why you should listen
Seth Berkley is an epidemiologist and the CEO of Gavi, the Vaccine Alliance, the global health organization protecting lives by improving access to vaccines in developing countries. Seth joined Gavi in 2011 in a period of rapid acceleration of Gavi’s programs. Now, with more than half a billion children immunized, he is leading Gavi’s efforts to reach a further 300 million children in the next five years and build sustainability into country immunization programs. Prior to Gavi, he spearheaded the development of vaccines for HIV as founder and CEO of the International AIDS Vaccine Initiative.
Seth Berkley | Speaker | TED.com